- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02552160
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy (DETECT)
10 december 2018 uppdaterad av: AstraZeneca
Non-interventional Study for Documentation of the Therapeutic Efficacy, Use and Tolerance of the Fixed-Dose Combinations (FDC) Duaklir® Genuair® (Aclidinium/Formoterol), Ultibro® Breezhaler® (Glycopyrronium/Indacaterol) and Anoro® (Umeclidinium/Vilanterol) in the Treatment of COPD Under Real Conditions in the Practices of Pneumologists, Internists, and General Practitioners
Prospective, multi-centre, non-interventional study to collect findings about the effects of LABA/LAMA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists) combination preparations on COPD (Chronic obstructive pulmonary disease) symptoms and quality of life under real conditions and to find out what types of patients are selected for this therapy by physicians.
Studieöversikt
Status
Avslutad
Betingelser
Detaljerad beskrivning
Retrospective aspect of documentation: For patients who have already been changed over to a fixed-dose combination, lung function parameters and CAT (COPD Assessment Test™) score from the time prior to the changeover will be documented.
Studietyp
Observationell
Inskrivning (Faktisk)
3732
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
D6570r00001
-
Aachen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Aldenhofen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Aldenhoven, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Alzey, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ansbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Apolda, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Aschau, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Auerbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Augsburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Fallingbostel, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Hersfeld, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Honnef, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Lippspringe, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Reichenhall, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Sachsa, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Windsheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bad Woerishofen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bamberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Beelitz-Heilstaetten, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bergisch Gladbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Berlin, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Biberach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Birkenwerder, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bitterfeld-Wolfen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bochum, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Boehlen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bonn, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bottrop, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Braunschweig, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Bruchsal, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Buechen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Burghaslach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Burgwedel, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Celle, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Chemnitz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Cottbus, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Darmstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Delitzsch, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Dessau, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Dorsten, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Dortmund, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Dresden, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Dueren, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Duesseldorf, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Duisburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Eimsheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ellerstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Elsterwerda, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Elterlein, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Essen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Euerbach-Obbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Euskirchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Flensburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Frankfurt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Frankfurt/M., D6570r00001, Tyskland, D6570R00001
- Research Site
-
Freiberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Fuerstenwalde, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Fuerth, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ganderkesee, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Garching, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Garmisch-Partenkirchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Gauting, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Gera, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Gerwisch, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Glienicke, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Greiz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Guetersloh, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hagen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Halberstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Halle, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hamburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hannover, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hartenstein, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Heidelberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hemmingen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hettstedt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hoechstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Hoyerswerda, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ibbenbueren, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ingolstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Iserlohn, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Issum, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Jena, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Karlsruhe, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Kevelaer, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Kleve, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Koeln, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Koeln-Hoehenberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Koeln-Rodenkirchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Koethen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Kolbermoor, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Krefeld, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Kronach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Kyritz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Langenfeld, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Leer, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Leipzig, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Leonberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Lippstadt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ludwigsburg-Ossweil, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ludwigshafen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Luebeck, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Magdeburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Mainz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Mannheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Marburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Markt Bibart, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Menden, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Merzig, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Moenchengladbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Moers, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Monheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Mosbach, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Muehlhausen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Muenchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neumarkt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neunkirchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neuruppin, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neusaess, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neustadt/Aisch, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Neuwied, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Nuernberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Oettingen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Oschatz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Oy-Mittelberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Pirmasens, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Potsdam, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Pulheim-Braunweiler, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Radebeul, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Rastatt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Rathenow, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Recklinghausen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Remscheid, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Reutlingen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Rosenheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Rostock, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Roth, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ruedersdorf, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ruesselsheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Rust, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Saalfeld, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Saarbruecken, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Saarlouis, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Schleswig, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Schmoelln, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Schoenbrunn, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Schwedt, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Siegen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Simmern, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Solingen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Sonsbeck, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Spiesen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Spremberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Steinhagen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Strasskirchen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Strausberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Stuttgart, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Sulzberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Teterow, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Teuchern, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Thaleischweiler-Froeschen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Trier, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ulm, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Unterwellenborn, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Ursensollen, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Voerde, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wallenhorst, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wardenburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Waren, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Warendorf, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wehrheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Weilheim, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Weissenburg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Weisswasser, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wiesbaden, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Witten, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wittenberg, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Worms, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Wuppertal, D6570r00001, Tyskland, D6570R00001
- Research Site
-
Zwoenitz, D6570r00001, Tyskland, D6570R00001
- Research Site
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
40 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Testmetod
Sannolikhetsprov
Studera befolkning
Patients who have been diagnosed with COPD (Chronic obstructive pulmonary disease), who have been changed over within the last 3 months to one of the 3 listed fixed-dose combinations (FDC) or for whom such a changeover is intended, and whose lung function parameters and CAT (COPD Assessment Test™) score from the time prior to the changeover are available (within the last 6 months) or are determined at the time of the 1st visit, if this is planned as part of the routine treatment.
Beskrivning
Inclusion Criteria:
- Female/male of at least 40 years of age
- Patient diagnosed with COPD
- Patient was changed over within the last 3 months to a fixed-dose combination (FDC) (Aclidinium/Formeterol, Glycopyrronium/Indacaterol or Umeclidinium/Vilanterol), or there is already the intent to change the patient over to a fixed-dose combination (Aclidinium/Formeterol, Glycopyrronium/Indacaterol or Umeclidinium/Vilanterol).
- Lung function parameters and CAT score from the time prior to the changeover to an FDC are on record (within the last 6 months in the case of patients who have already been changed over) or are determined at the 1st visit (in the case of patients who have not yet been changed over but for whom such a changeover is intended).
- Signed declaration of consent
Exclusion Criteria:
- The prescribing information for the fixed-dose combinations (Duaklir® Genuair®, Ulibtro® Breezhaler® or Anoro®) list contraindications for the patient.
- Patient is pregnant, plans to become pregnant, or is nursing during the therapy period.
- Patient suffers from hypersensitivity to one of the active ingredients of the fixed-dose combinations.
- Patient is participating in a clinical trial.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Patients on Duaklir® Genuair®
Patients on fixed-dose combination Duaklir® Genuair® (Aclidinium/Formoterol)
|
|
Patients on Ultibro® Breezhaler®
Patients on fixed-dose combination Ultibro® Breezhaler® (Glycopyrronium/Indacaterol)
|
|
Patients on Anoro®
Patients on fixed-dose combination Anoro® (Umeclidinium/Vilanterol)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Lung function
Tidsram: First visit (baseline)
|
Assessment of FEV1 (Forced Expiratory Volume), FVC (Forced Vital Capacity)
|
First visit (baseline)
|
|
Number of patients with concomitant diseases classified by diagnostic subgroups
Tidsram: First visit (baseline)
|
First visit (baseline)
|
|
|
Number of patients receiving concomitant COPD (Chronic obstructive pulmonary disease) medication classified by therapeutic subgroups
Tidsram: First visit (baseline)
|
First visit (baseline)
|
|
|
Number of patients with exacerbations within the previous 24 months
Tidsram: First visit (baseline)
|
History of previous exacerbations that will be collected at first observational visit.
|
First visit (baseline)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in well-being and quality of life
Tidsram: First visit (baseline) to end of observational period at 12 months
|
CAT (COPD Assessment Test™) questionnaire will be completed at each visit, approximately every 3 months.
|
First visit (baseline) to end of observational period at 12 months
|
|
Effect on the severity of the shortness of breath
Tidsram: First visit (baseline) to end of observational period at 12 months
|
mMRC (modified Medical Research Council Dyspnea Scale) questionnaire will be completed at each visit, approximately every 3 months.
|
First visit (baseline) to end of observational period at 12 months
|
|
Change in the night-time and early-morning COPD symptoms
Tidsram: First visit (baseline) to end of observational period at 12 months
|
NiSCI/EMSCI (Night-time symptoms of COPD Instrument / Early-morning symptoms of COPD instrument) questionnaire will be completed at each visit, approximately every 3 months.
|
First visit (baseline) to end of observational period at 12 months
|
|
Lung function
Tidsram: First visit (baseline) to end of observational period at 12 months
|
Assessment of FEV1, FVC at each visit, approximately every 3 months.
|
First visit (baseline) to end of observational period at 12 months
|
|
Number of exacerbations by grade
Tidsram: First visit (baseline) to end of observational period at 12 months
|
Number of exacerbations will be collected at each visit, approximately every 3 months
|
First visit (baseline) to end of observational period at 12 months
|
|
Adverse events
Tidsram: First visit (baseline) to end of observational period at 12 months
|
Adverse events will be collected at each visit, approximately every 3 months.
|
First visit (baseline) to end of observational period at 12 months
|
|
Handling of inhaler
Tidsram: At 12 months
|
Questionnaire regarding handling of inhaler by patient
|
At 12 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Användbara länkar
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
24 september 2015
Primärt slutförande (Faktisk)
31 december 2017
Avslutad studie (Faktisk)
31 december 2017
Studieregistreringsdatum
Först inskickad
29 juli 2015
Först inskickad som uppfyllde QC-kriterierna
16 september 2015
Första postat (Uppskatta)
17 september 2015
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
11 december 2018
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
10 december 2018
Senast verifierad
1 december 2018
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- D6570R00001
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .